Eikon Therapeutics
Director, Financial Planning & Analysis
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
Position Summary
We are seeking a Director, Financial Planning & Analysis (FP&A) to lead financial reporting, budgeting, forecasting, and process optimization at Eikon. Reporting to the Executive Director, Finance, you will play a critical role in ensuring financial accuracy, enhancing operational efficiency, and providing strategic insights that support decision-making across the organization.
This role is an opportunity to shape financial strategy, drive operational improvements, and work cross-functionally with teams including Research, Engineering, and Operations.
About You
You are a seasoned finance leader with deep expertise in financial planning and analysis within the biotech, pharmaceutical, or healthcare industries. You have a strategic mindset, technical expertise, and a keen eye for process improvement. Your ability to transform complex financial data into clear, actionable insights makes you a trusted partner to senior leadership. You thrive in fast-paced, high-growth environments and excel at fostering collaboration across functions.
Key Responsibilities
- Develop & Implement Financial Strategy – Align financial planning with Eikon’s business objectives to drive sustainable growth.
- Lead Budgeting & Long Range Planning Processes – Ensure accuracy and efficiency in financial planning using data-driven insights and predictive modeling.
- Optimize Financial Reporting & Performance Management – Develop key performance indicators (KPIs), financial scorecards, and business review frameworks.
- Collaborate on Corporate Finance Initiatives – Partner with Executive management on capital formation initiatives and partner with the Business Development team on licensing and partnership opportunities
- Enhance Financial Governance & Compliance – Maintain internal financial controls, ensure regulatory compliance, and uphold industry best practices.
- Support Decision-Making with Actionable Insights – Deliver financial reports that highlight risks, opportunities, and trends for executive leadership.
- Streamline Financial Operations – Drive efficiency in budgeting, accruals, and reporting processes to enhance reliability and reduce cycle times.
- Strengthen Cross-Functional Collaboration – Partner with Research, Engineering, and other teams to align financial strategies with operational needs.
- Leverage Advanced FP&A Tools & Systems – Utilize Anaplan and other financial platforms to improve forecasting, reporting, and resource allocation.
- Improve Cost Transparency & Resource Allocation – Ensure financial data is clear, reliable, and supports strategic business decisions.
Qualifications & Experience
- 12+ years of experience with a Bachelor's Degree or 10+ years of experience with a post graduate degree in financial planning, analysis, or accounting, preferably within biotech, pharma, or healthcare.
- Bachelor's degree in finance, accounting, or a related field (MBA and/or CPA preferred but not required).
- Strong technical and analytical skills – Expertise in Anaplan, financial modeling, and data visualization tools.
- Proven experience in process optimization – Ability to improve financial workflows, enhance reporting accuracy, and drive efficiency.
- Flawless attention to detail – Skilled in managing complex financial data with precision.
- Excellent business acumen & collaboration skills – Ability to work cross-functionally and align finance with organizational priorities.
- Effective communication and reporting – Capable of presenting clear, concise financial insights to senior executives.
At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:
- 401k plan with company matching
- Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)
- Mental health and wellness benefits
- Weeklong summer and winter holiday shutdowns
- Generous paid time off and holiday policies
- Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies
- Enhanced parental leave benefit
- Daily subsidized lunch program when on-site
The expected salary range for this role is $204,000 to $223,250 depending on skills, competency, and the market demand for your expertise.
Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.
We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.
Top Skills
Eikon Therapeutics Hayward, California, USA Office
3929 Point Eden Way, Hayward, California, United States, 94545
Similar Jobs
.png)
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
